Trials / Completed
CompletedNCT02099370
Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients
A Single-center Prospective Measurement of Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are measuring the adherence rates of an oral MS drug that is to be administered twice-daily. The investigators would like to observe any patterns that might indicate factors that greatly affect adherence.
Conditions
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2014-03-28
- Last updated
- 2020-04-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02099370. Inclusion in this directory is not an endorsement.